Global Intellectual Property Specialists

Strategic global thinking for the pharmaceutical and biopharmaceutical industries

Our Capabilities

We use our global experience to support life sciences clients from early R&D to commercial launch, and beyond.

Explore our BioBlast®

View our interactive biosimilar news updates, collating tailored reports by brand, INN, originator/biosimilar applicant, litigation, region, or date.

Our People

Our lawyers and attorneys have science backgrounds, were trained at top tier firms, and most have experience in-house at multinational giants.

Award-winning IP services

Ranked internationally and domestically, our pharmaceutical, biopharmaceutical and life sciences focussed lawyers and attorneys are recognised as being among the best IP practitioners in the world.

Our Capabilities

Pearce IP is a boutique firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys, to the pharmaceutical, biopharmaceutical and life sciences industries.

With staff based in Australia and New Zealand, we coordinate and execute local and multi-jurisdictional IP litigation strategies, provide IP/legal support for regional and global business development activities and licensing deals, and prosecute patent and trade mark applications around the world.

Patent: Legal and Attorney Services

Trade Mark: Legal and Attorney Services

Commercial IP Services

Regulatory Affairs Services

View our Capabilities

Since its establishment in 2017 boutique Pearce IP has dominated in the area of pharmaceutical patents. Thanks to its deep bench of talented professionals, any life sciences brief is dispatched with alacrity and poise.

IAM Patent 1000, 2024

IP SPECIALIST LAWYERS – PATENT ATTORNEYS – TRADE MARK ATTORNEYS

Our Leaders

Naomi Pearce

CEO, Executive Lawyer (AU, NZ), Patent & Trade Mark Attorney (AU, NZ)

Adele Chadwick

Executive, Deputy CEO & Head of Talent

Paul Johns

Executive, Lawyer (Head of Litigation - New Zealand)

Kimberley Evans

Executive, Lawyer & Trade Mark Attorney (Head of Trade Marks - Australia)

Chris Coates (Maj Ret)

Executive, Finance

Julie Ballance

Executive, Patent Attorney and Trade Mark Practitioner (AU, NZ), Lawyer (NZ) & Notary (NZ)

Sally Paterson

Executive, Patent & Trade Mark Attorney (AU, NZ), Lawyer (NZ)

Helen Macpherson

Executive, Lawyer (Head of Litigation - Australia)

PEARCE IP BLOG

Read our latest updates & insights

When “Routine Chemistry” Isn’t Routine – Key Lessons from a Recent APO Decision

by Sally Paterson, Helen Macpherson | Feb 4, 2026

IP Australia has dismissed Adama Agan Ltd’s (Adama) opposition to the grant of Kumiai Chemical Industry Co., Ltd’s (Kumiai) Australian patent application directed to an industrial process for producing the herbicide pyroxasulfone, with Kumiai’s patent application proceeding to grant in early January 2026.

Pearce IP BioBlast® for the week ending 30 January 2026

by Naomi Pearce, Paul Johns, Chantal Savage | Feb 3, 2026

Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 30 January 2026 are set out below…

CSIRO’s Wheat Taste of Victory – Finding of Unsupported Patent Claims Overturned in Unopposed Appeal

by Paul Johns, Sally Paterson, Helen Macpherson | Feb 2, 2026

Justice Beach of the Federal Court of Australia has granted an appeal by CSIRO overturning the APO decision that CSIRO’s patent application number AU 2017292900 (the Application) was invalid due to lack of support.